What is the liver-brain axis, and does it play a role in dementia?

Health & Lifestyle
446

Listen to article (english)

Translate to Spanish or other 102 languages!

What does liver health have to do with the brain? Image for illustration purposes
What does liver health have to do with the brain? Image for illustration purposes

Medical News Today

- Advertisement -

Recent research has shown that the liver and the brain are closely connected and can affect each other’s functions. So, could liver health influence a person’s dementia risk? Here is what experts and the most recent research have to say.

Through recent studies, scientists have found that liver-related conditions, such as liver fibrosis and nonalcoholic fatty liver disease (NAFLD), are linked to cognitive decline and changes in the brain’s structure.

Follow the link below to read the full story on Medical News Today:

- Advertisement -

https://www.medicalnewstoday.com/articles/what-is-the-liver-brain-axis-and-does-it-play-a-role-in-dementia

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
10 Quick Facts About Sarcoma, One of The Rarest Cancers
Next article
Does Osteoporosis Run in Your Family?

More Articles

The Truth About Liver Detoxes

Many health trends seem to come and go, but there are some that always find a way of resurfacing – like detoxing your liver.

STHS Children’s Webinar to Help Parents Protect Young Athletes from Sports-Related Injuries, Aug. 19th

Whether competing in youth sports, high school athletics or recreational leagues, young athletes continually push themselves to perform at their best. 

CDC Issues Warning Over Multistate Salmonella Outbreak Linked to Jalapeños

The Centers for Disease Control and Prevention (CDC) has issued a food safety alert following a multistate outbreak of Salmonella infections linked to contaminated jalapeño peppers

New Blood Test Spots Early Signs of Immunotherapy Effectiveness

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy determined that liquid biopsy—a blood test that detects circulating tumor DNA (ctDNA)—can predict, within a few weeks, whether patients with advanced non-small cell lung cancer are benefiting from immunotherapy.
- Advertisement -